This report evaluates the potential of the antidepressant drug citalopram to induce homozygotization of genes previously present in a heterozygous condition, by homologous recombination. In order to address this question, a heterozygous diploid strain of the filamentous fungus Aspergillus nidulans and the homozygotization assay were utilized. Non-cytotoxic concentrations of citalopram (50, 75 and 100 μmol/L) showed a strong recombinogenic effect in A. nidulans, inducing homozygosis of the diploid strain's nutritional markers. The genetic markers exhibited homozygotization index (HI) rates higher than 2.0 and significantly different from HI control ones. Since citalopram has been previously characterized as a DNA synthesis inhibitor, the recombinogenic potential of this antidepressant in A. nidulans may be associated with the recombinational repair of citalopram-induced DNA strand breaks.
DeJongM, FombonneE. Citalopram to treat depression in pediatric oncology. J Child Adolesc Psychopharmacol2007;17:371–7
2.
OhayonMM, LaderMH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry2002;63:817–25
3.
StaffordRS, MacDolaldEA, FinkelsteinSN. National patters of medication treatment for depression 1987 to 2001. Prim Care Companion J Clin Psychiatry2001;3:232–5
BozkurtG, AbayE, AtesI, KarabogazG, TureM, SavranFO, PalanduzS, TemocinK, AlgunesC. Clastogenicity of selective serotonin-reuptake inhibitors. Mutat Res2004;558:137–44
6.
Hilakivi-ClarkeL, WrightA, LippmanME. Neonatal antidepressant treatment promotes DMBA-induced mammary tumor growth. Proc Am Assoc Cancer Res1993;34:184
7.
BrandesLJ, ArronRJ, BogdanovicRP, TongJ, ZaborniakCLF, HoggGR, WarringtonRC, FangW, LabellaFS. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res1992;52:3796–800
8.
MoormanPG, GrubberJM, MillikanRC, NewmanB. Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology2003;14:307–14
9.
SteingartA, CotterchioM, KreigerN, SloanM. Antidepressant medication use and breast cancer risk: a case-control study. Int J Epidemiol2003;32:961–6
10.
KellyJP, RosenbergL, PalmerJR, RaoRS, StromBL, StolleyPD, ZauberAG, ShapiroS. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol1999;150:861–8
11.
ChienC, LiCI, HeckbertSR, MaloneKE, BoudreauDM, DalingJR. Antidepressant use and breast cancer risk. Breast Cancer Res Treat2006;95:131–40
12.
WangPS, WalkerAM, TsuangMT, OravEJ, LevinR, AvornJ. Antidepressant use and risk of breast cancer: a non association. J Clin Epidemiol2001;54:728–34
13.
Van der HeijdenMS, YeoCJ, HrubanRH, KernSE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res2003;63:2585–8
14.
SteingartAB, CotterchioM. Do antidepressants cause, promote, or inhibit cancers?J Clin Epidemiol1995;48:1407–12
15.
TanakaK, MansoorAM, ShigetaC, OgumaN, KamadaN. Loss of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. Cancer Genet Cytogenet1992;61:42–5
16.
HowarthK, RantaS, WinterE, TeixeiraA, SchaschlH, HarveyJJ, RowanA, JonesA, SpainS, ClarkS, GuentherT, StewartA, SilverA, TomlinsonI. A mitotic recombination map proximal to the APC locus on chromosome 5q and assessment of influences on colorectal cancer risk. BMC Med Genet2009;10:1–11
PayneM, HicksonID. Genomic instability and cancer: lessons from analysis of Bloom's syndrome. Biochem Soc Trans2009;37:553–9
19.
LuoG, SantoroIM, McDanielLD, NishijimaI, MillsM, YoussoufianH, VogelH, SchultzRA, BradleyA. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet2000;26:424–9
20.
ChagantiRS, SchonbergS, GermanJ. A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc Natl Acad Sci USA1974;71:4508–12
21.
BergenGG, MorrisNR. Kinetics of the nuclear division cycle of Aspergillus nidulans. J Bacteriol1983;156:155–60
22.
Castro-PradoJ, FrancoCCS, SantannaJR, MiyamotoCT, Castro-PradoMAA. Recombinogenic activity of fluoxetine in Aspergillus nidulans. Drug Chem Toxicol2009;32:338–43
23.
Sant'AnnaJR, MiyamotoCT, FrancoCCS, MiguelOG, CunicoMM, CôccoLC, YamamotoCI, JúniorCC, Castro-PradoMAA. Genotoxicity of Achillea millefolium essential oil in diploid cells of Aspergillus nidulans. Phytother Res2009;23:231–5
24.
MiyamotoCT, Sant'AnnaJR, FrancoCCS, Castro-PradoMAA. Genotoxicity (mitotic recombination) of the cancer chemotherapeutic agents cisplatin and cytosine arabinoside in Aspergillus nidulans. Food Chem Toxicol2007;45:1091–5
25.
ArnaudeauC, TenorioMiranda E, JensenD, HelledayT. Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells. Mutat Res2000;461:221–8
26.
DhawanA, KayaniMA, ParryJM, ParryE, AndersonD. Aneugenic and clastogenic effects of doxorrobicin in human lymphocytes. Mutagenesis2003;18:487–90
27.
HelenKDB, SubramanyamS. Genotoxic evaluation of ara-c by multiple parameters. Mutat Res1991;263:185–96
28.
BeckerTCA, Castro-PradoMAA. Parameiosis in Aspergillus nidulans in response to doxorubicin. Folia Microbiol2004;49:699–704
29.
RoperJA. Production of heterozygous diploids in filamentous fungi. Experientia1952;8:14–15
30.
SerafeinA, HolderMJ, GraftonG, ChambaA, DraysonMT, LuongQT, BunceCM, GregoryCD, BarnesNM, GordonJ. Selective serotonin inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood2003;101:3212–19
31.
KaneshimaEN, Castro-PradoMAA. Benznidazole-induced genotoxicity in diploid cells of Aspergillus nidulans. Mem Inst Oswaldo Cruz2005;100:325–9
32.
SantosSJ, TakahashiCS, NatarajanAT. Cytogenetic effects of the antichagasic benznidazole on human cells in vitro. Mutat Res1994;320:305–14
33.
WillersH, McCarthyEE, WuB. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene2000;19:632–9
34.
SzewczukW, SkomraD, CybulskiM, dka-RabaniukDP, FilipA, JóźwikM, OlchaP, RoessnerA, SemczukA. Allelic loss at TP53 in metastatic human endometrial carcinomas. Clin Exp Metastasis2009;26:789–96
35.
YangQ, ZhangR, WangXW, SpillareEA, LinkeSP, SubramaniansD, GriffithJD, LiJL, HicksonID, ShenJC, LoebLA, MazurSJ, AppellaE, BroshRM, KarmakarP, BohrVA, HarrisCC. The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J Biol Chem2002;277:31980–7
36.
HainautP, HollsteinM. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res2000;77:81–137
37.
LaskoD, CaveneeW, NordenskjoldM. Loss of constitutional heterozygosity in human cancer. Ann Rev Genet1991;25:281–314
38.
SchildD, WieseC. Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res2010;38:1061–70
39.
VenkitaramanAR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell2002;108:171–82
40.
BishopAJR, SchiestlRH. Homologous recombination and its role in carcinogenesis. J Biomed Biotechnol2002;2:75–85
41.
Rousseau-MerckMF, VersteegeI, LegrandI, CouturierJ, MairalA, DelattreO, AuriasA. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res1999;59:3152–6
42.
GrundyP, WilsonB, TelzerowP, ZhouW, PatersonMC. Uniparental disomy occurs infrequently in Wilms' tumor patients. Am J Hum Genet1994;54:282–9
43.
ZhuX, DunnJM, GoddardAD, SquireJA, BeckerA, PhillipsRA, GallieBL. Mechanisms of loss of heterozygosity in retinoblastoma. Cytogenet Cell Genet1992;59:248–52
44.
RoscoeJA, MorrowGR, HickokJT, MustianKM, GriggsJJ, MattrsonSE, BushunowP, QaziR, SmithB. Effect of paroxetine hydrochloride (Paxil®) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat2005;89:243–9
45.
FischM. Treatment of depression and cancer. J Natl Cancer Inst Monogr2004;32:105–11
46.
FischMJ, LoehrerPJ, KristellerJ. Fluoxetina versus placebo in advanced cancer outpatients: a double-blinded trial of the hoosier oncology group. J Clin Oncol2003;21:1937–43
47.
PortteusA, AhmadN, TobeyD, LeaveryPL. The prevalence and use of antidepressant medication in pediatric cancer patients. J Child Adolesc Psychopharmacol2006;16:467–73
48.
XiaZ, LundgrenB, BergstrandA, DePierreJW, NässbergerL. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and Citalopram and the effects on these changes by Bcl-2 and Bcl-XL. Biochem Pharmacol1999;57:1199–208
49.
WernliKJ, HamptonJM, Trentham-DietzA, NewcombA. Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf2009;18:284–90
